Karyopharm Therapeutics (KPTI) Non-cash Items (2012 - 2025)

Karyopharm Therapeutics has reported Non-cash Items for 12 years, with the latest figure at $210218.0 in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items changed N/A year-over-year to $210218.0; the trailing twelve-month figure through Dec 2025 stood at $210218.0 (changed N/A YoY), and the FY2025 full-year result was $210218.0, changed N/A from the prior year.
• Non-cash Items for Q4 2025 stood at $210218.0, up from $6000.0 in the prior quarter.
• The five-year high for Non-cash Items was $2.3 million in Q4 2021, with the low at $6000.0 in Q4 2022.
• Historically, Non-cash Items has averaged $835072.7 across 3 years, with a median of $210218.0 in 2025.
• Annual changes were most pronounced in 2021 — Non-cash Items sank 94.8% — and 2022, when it tumbled 99.74%.
• Karyopharm Therapeutics' Non-cash Items stood at $2.3 million in 2021, then plunged by 99.74% to $6000.0 in 2022, then surged by 3403.63% to $210218.0 in 2025.
• The last three Non-cash Items figures came in at $210218.0 (Q4 2025), $6000.0 (Q4 2022), and $2.3 million (Q4 2021), per Business Quant data.